Biomarkers – Products

Aptamer Group plc is pleased to announce the successful adaptation of the Optimer-based test for Alzheimer’s disease into an Enzyme-Linked Immunosorbent Assay (ELISA).

Scipher and InnoSIGN partner to decode immune diseases using RNAseq and AI-based signaling pathway analysis.

Click here for further information!

A new study highlights IsoPSA’s ability to identify low-risk prostate cancer patients who can avoid unnecessary interventions. The test also helps monitor high-risk patients more closely.

PGxAI's Deneb model uses AI and multi-omics data to predict patient drug responses, streamlining drug development and reducing trial failures.

Oxford Nanopore and Cepheid to co-develop a rapid sequencing workflow for in-house infectious disease diagnostics.

Signios Bio, formerly the US research division of MedGenome, has rebranded to reflect its bold vision in AI-powered bioinformatics and multiomics. With an integrated suite of technologies spanning genomics, proteomics and spatial biology.

Canopy Multiomic Services delivers advanced tools for spatial biology and single-cell omics, supporting biopharma research, assay development, clinical testing, and quality data—guiding your work from discovery to translation

DNAnexus and Alida Biosciences collaborate to advance RNA epigenomics by hosting AlidaBio's EpiScout™ Analysis Suite on the DNAnexus cloud platform.

This application note explores how electrophoretic methods surpass the capabilities of traditional methods to accurately distinguish between cfDNA and contaminating high molecular weight (HMW) DNA, making them ideal for cfDNA quality control.